Global Non-invasive Helicobacter Pylori Diagnostic Testing Market Growth (Status and Outlook) 2023-2029

Global Non-invasive Helicobacter Pylori Diagnostic Testing Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Non-invasive Helicobacter Pylori Diagnostic Testing Industry Forecast” looks at past sales and reviews total world Non-invasive Helicobacter Pylori Diagnostic Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Non-invasive Helicobacter Pylori Diagnostic Testing sales for 2023 through 2029. With Non-invasive Helicobacter Pylori Diagnostic Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-invasive Helicobacter Pylori Diagnostic Testing industry.

This Insight Report provides a comprehensive analysis of the global Non-invasive Helicobacter Pylori Diagnostic Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-invasive Helicobacter Pylori Diagnostic Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-invasive Helicobacter Pylori Diagnostic Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-invasive Helicobacter Pylori Diagnostic Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-invasive Helicobacter Pylori Diagnostic Testing.

The global Non-invasive Helicobacter Pylori Diagnostic Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Non-invasive Helicobacter Pylori Diagnostic Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Non-invasive Helicobacter Pylori Diagnostic Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Non-invasive Helicobacter Pylori Diagnostic Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Non-invasive Helicobacter Pylori Diagnostic Testing players cover Sekisui Diagnostics, F. Hoffmann-La Roche, Medline Industries, Meridian Bioscience, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories, EKF Diagnostics and Quidel, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive Helicobacter Pylori Diagnostic Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Invasive Techniques
Non-invasive Techniques

Segmentation by application
Hospitals and Clinics
Diagnostic Laboratories

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sekisui Diagnostics
F. Hoffmann-La Roche
Medline Industries
Meridian Bioscience
Bio-Rad Laboratories
Thermo Fisher Scientific
Alpha Laboratories
EKF Diagnostics
Quidel
Halyard Health
Cardinal Health
Beckman Coulter
Agilent Technologies
Coris BioConcept

Please note: The report will take approximately 2 business days to prepare and deliver.